Search for: "Watson Laboratories, Inc. et al v. Bayer Pharma AG et al"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
19 Feb 2012, 8:55 pm
Watson Pharmaceuticals, Inc. et al. 2:12-cv-00223; filed February 13, 2012 in the District Court of Nevada • Plaintiffs: Merck & Cie; Bayer Pharma AG; Bayer Healthcare Pharmaceuticals Inc. [read post]
9 Oct 2009, 9:11 am
(patent infringement) 9/15: Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc., Schering Corporation v. [read post]
17 Feb 2010, 8:00 am
Watson Pharmaceuticals Inc., Watson Laboratories Inc. and Watson Pharma Inc. [read post]
28 Jul 2010, 12:06 am
Watson Laboratories, Inc. [read post]
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
30 Dec 2016, 7:38 am
" Bayer Pharma AG et al v. [read post]
6 Apr 2011, 12:18 am
Patent and Trademark Office, et. al. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
